Canopy Biosciences and Enable Medicine Announce Partnership to Bring Advanced Spatial Analysis Pipelines to the ChipCytometry Platform

Enable Cloud Platform to be Available with Canopy CellScape System for High-Plex Spatial Biology ST. LOUIS & MENLO PARK, Calif.–(BUSINESS WIRE)– Canopy Biosciences, a Bruker Company, and Enable Medicine, today announced a partnership to provide Enable Medicine’s advanced analysis pipelines for spatial omics data with the Canopy CellScape™ system for quantitative high-plex spatial biology. The... Read more

Danaher Announces Conversion Date for Series B Mandatory Convertible Preferred Stock

Danaher Announces Conversion Date for Series B Mandatory Convertible Preferred Stock WASHINGTON, April 10, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that its 5.00% Series B Mandatory Convertible Preferred Stock (the “Preferred Stock”), will automatically convert into shares of the Company’s common stock on April 17, 2023 (the “Conversion Date”). The conversion rate... Read more

Thermo Fisher Scientific Opens Cell Therapy Facility at University of California, San Francisco, to Accelerate Development of Breakthrough Therapies

WALTHAM, Mass. & SAN FRANCISCO–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and the University of California, San Francisco (UCSF), will accelerate advanced cell therapies for difficult to treat conditions, including cancer, rare diseases, and other illnesses, from a newly opened cGMP manufacturing facility adjacent to UCSF Medical Center’s... Read more

Danaher Schedules First Quarter 2023 Earnings Conference Call

WASHINGTON, March 27, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2023 on Tuesday, April 25, 2023 beginning at 8:00 a.m. ET and lasting approximately 1 hour. During the call, the company will discuss its financial performance, as well as future expectations.... Read more

Bruker Announces Two 1.2 GHz NMR Systems Orders from the UK

Universities of Warwick and Birmingham to receive 1.2 GHz NMRs for Enabling Life-Science and Green-Tech Research throughout the United Kingdom COVENTRY, United Kingdom–(BUSINESS WIRE)– Bruker announces that the United Kingdom is expanding its fundamental research infrastructure with recent orders for two 1.2 GHz Avance™ nuclear magnetic resonance (NMR) spectrometers for the University of Warwick and... Read more

Danaher Partners with the University of Pennsylvania's Center for Cellular Immunotherapies to Address Manufacturing Challenges Impacting the Uptake of Cell Therapies

Danaher Partners with the University of Pennsylvania’s Center for Cellular Immunotherapies to Address Manufacturing Challenges Impacting the Uptake of Cell Therapies WASHINGTON, March 7, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced a strategic partnership with the University of Pennsylvania (Penn) focusing on cell therapy innovation. The multi-year... Read more

Bruker Launches de novo Sequencing for Immunopeptidomics, Library-Free dia-PASEF, Mass Dynamics Knowledge Visualization

PaSER™ Novor faster, real-time de novo sequencing for immunopeptidomics Library-free dia-PASEF® analysis with PaSER 2023b proteomics software Partnership with Mass Dynamics for 4D-Proteomics™ knowledge visualization CHICAGO–(BUSINESS WIRE)– At the 19th US HUPO, Bruker Corporation (Nasdaq: BRKR) announced important bioinformatics launches for 4D-Proteomics on the timsTOF platform: A novel de novo sequencing algorithm was developed in... Read more

Thermo Fisher Scientific to Present at Cowen 43rd Annual Healthcare Conference on March 6, 2023

WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the Cowen Healthcare Conference on Monday, March 6, 2023 at 9:10 a.m. (EST). You can access the webcast of the presentation via the Investors section of... Read more